Sujal Shah is CEO at CymaBay Therapeutics, Inc. (CBAY). They have made 11 open-market trades across 2 companies since 2014, most recently 2024-03-22.
CIK 0001588861
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
11 open-market purchases totalling $789K since 2014, never a sale. Across 10 scored buys the stock is up 1.6% at ninety days, and 1.1 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CBAY | 364,808 | $11.8M |
| PrivateUnlisted | 10,000 | — |
| Total | $11.8M |
Shares reported on the most recent Form 4, priced at the 2024-03-15 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 30% | 70% | 50% |
| Avg Move | -1.3% | +14.7% | +1.6% |
| Alpha | +0.1% | +13.4% | -1.1% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBAY | SELL · 10b5-1 | 2023-12-11 | 2023-12-11 | $20.00 | $2.6M | +8.1% | +13.7% | +57.9% |
| CBAY | SELL · 10b5-1 | 2023-11-13 | 2023-11-14 | $15.89 | $2.1M | +5.9% | +26.0% | +87.5% |
| CBAY | SELL · 10b5-1 | 2023-10-09 | 2023-10-10 | $14.20 | $1.8M | -4.8% | +3.9% | +64.8% |
| CBAY | BUY | 2022-06-06 | 2022-06-07 | $1.95 | $200K | -14.3% | +39.1% | +48.3% |
| CBAY | BUY | 2019-10-10 | 2019-10-15 | $4.30 | $22K | -0.9% | +15.0% | -59.6% |
| CBAY | BUY | 2019-09-20 | 2019-09-24 | $5.53 | $28K | -8.5% | -16.0% | -64.5% |
| CBAY | BUY | 2018-12-21 | 2018-12-21 | $6.54 | $65K | +33.3% | +36.0% | +97.3% |
| CBAY | BUY | 2018-10-15 | 2018-10-16 | $9.90 | $50K | -8.1% | -14.5% | -14.5% |
| CBAY | BUY | 2018-07-27 | 2018-07-30 | $10.90 | $55K | +6.5% | +17.8% | -14.5% |
| CBAY | BUY | 2018-05-11 | 2018-05-15 | $10.65 | $53K | -3.1% | +11.8% | +3.8% |
| CBAY | BUY | 2017-07-20 | 2017-07-24 | $7.34 | $132K | -11.5% | -20.4% | -2.7% |
| CBAY | BUY | 2016-04-04 | 2016-04-06 | $1.39 | $76K | +17.4% | +68.8% | +13.9% |
| CBAY | BUY | 2015-05-18 | 2015-05-19 | $3.40 | $34K | -23.4% | +9.0% | +9.0% |
| PrivateCymaBay Therapeutics, Inc. | BUY | 2014-09-16 | 2014-09-17 | $7.44 | $74K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.